Concepedia

Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme

Ruth E. Langley, Duncan C. Gilbert, Trinh Duong, Noel W. Clarke, Matthew Nankivell, Stuart D. Rosen, Stephen Mangar, Archie Macnair, S.K. Sundaram, Marc Laniado,

The Lancet · 2021 · 40 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Risk of Fracture after Androgen Deprivation for Prostate Cancer

Vahakn B. Shahinian, Yong‐Fang Kuo, Jean L. Freeman et al. · New England Journal of Medicine · 2005 · 1.4K citations

Effects of Postmenopausal Estrogen Replacement on the Concentrations and Metabolism of Plasma Lipoproteins

Brian W. Walsh, Isaac Schiff, Bernard Rosner et al. · New England Journal of Medicine · 1991 · 1.2K citations · Full text

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Chris Parker, Elena Castro, Karim Fizazi et al. · Annals of Oncology · 2020 · 903 citations · Full text

, , +4

Changes in Body Composition during Androgen Deprivation Therapy for Prostate Cancer

Matthew R. Smith, Joel S. Finkelstein, Francis J. McGovern et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 661 citations · Full text

, , +14

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Alan Horwich, Chris Parker, C. Bangma et al. · Annals of Oncology · 2010 · 599 citations · Full text

, , +4